Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021

SELL
$76.38 - $86.03 $10.1 Million - $11.4 Million
-132,579 Closed
0 $0
Q4 2020

Feb 25, 2021

BUY
$75.39 - $82.36 $217,575 - $237,690
2,886 Added 2.23%
132,579 $10.6 Million
Q3 2020

Nov 10, 2020

SELL
$78.33 - $90.73 $132,377 - $153,333
-1,690 Reduced 1.29%
129,693 $10.4 Million
Q2 2020

Aug 10, 2020

SELL
$78.66 - $94.14 $250,610 - $299,930
-3,186 Reduced 2.37%
131,383 $11.3 Million
Q1 2020

May 22, 2020

SELL
$71.57 - $93.3 $833,862 - $1.09 Million
-11,651 Reduced 7.97%
134,569 $10.9 Million
Q4 2019

Feb 20, 2020

SELL
$76.7 - $88.45 $223,197 - $257,389
-2,910 Reduced 1.95%
146,220 $12.2 Million
Q3 2019

Nov 19, 2019

SELL
$81.4 - $89.78 $193,569 - $213,496
-2,378 Reduced 1.57%
149,130 $13 Million
Q2 2019

Aug 05, 2019

SELL
$73.44 - $82.41 $1.26 Million - $1.41 Million
-17,117 Reduced 10.15%
151,508 $12.4 Million
Q1 2019

May 02, 2019

BUY
$64.48 - $81.31 $690,000 - $870,098
10,701 Added 6.78%
168,625 $13.7 Million
Q4 2018

Feb 12, 2019

BUY
$61.45 - $77.8 $719,702 - $911,193
11,712 Added 8.01%
157,924 $10.4 Million
Q3 2018

Nov 05, 2018

SELL
$70.71 - $77.75 $150,753 - $165,763
-2,132 Reduced 1.44%
146,212 $11.3 Million
Q2 2018

Aug 13, 2018

BUY
$63.43 - $75.41 $64,254 - $76,390
1,013 Added 0.69%
148,344 $11 Million
Q1 2018

May 09, 2018

BUY
$62.56 - $72.26 $263,690 - $304,575
4,215 Added 2.95%
147,331 $9.58 Million
Q4 2017

Feb 22, 2018

SELL
$61.45 - $66.05 $140,351 - $150,858
-2,284 Reduced 1.57%
143,116 $9.25 Million
Q3 2017

Nov 02, 2017

BUY
$59.5 - $64.61 $8.65 Million - $9.39 Million
145,400
145,400 $9.12 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $15.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Ccm Investment Advisers LLC Portfolio

Follow Ccm Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccm Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ccm Investment Advisers LLC with notifications on news.